February 1, 2017
UNC Lineberger's Shawn Hingtgen, PhD, and colleagues, in laboratory studies, have converted human skin cells into stem cells that can hunt down and kill human brain cancer, an important step to moving the approach closer to a clinical trial.
January 17, 2017
Backed by a three-year, more than $1.8 million grant from the National Cancer Institute, UNC Lineberger researchers Ryan Miller, MD, PhD, and Gary Johnson, PhD, plan to develop better cancer models to identify patterns of drug resistance in glioblastoma.
March 30, 2015
Results from a UNC Lineberger-led study were published Monday in the journal Molecular Cancer Therapeutics. The pre-clinical study was the first to investigate one particular drug strategy as a treatment for breast cancer after it's spread to the brain.
March 20, 2015
In early 2013, while pursuing a doctoral degree in theological anthropology at Trinity College in Dublin, Ireland, Lynn Latchford began to experience some puzzling symptoms. Routine academic tasks suddenly became difficult. Mental fogginess was accompanied by fatigue, weight gain and changes in her sense of smell, taste and hearing. Doctors attributed her symptoms to a chronic thyroid disorder and stress.
January 20, 2015
Timothy R. Gershon, MD, PhD, and Vivian Gama, PhD, have been announced as the 2015 recipients of the Weatherspoon Family Brain Tumor Research Award.
November 26, 2014
Matthew G. Ewend, MD, FACS, Van L. Weatherspoon, Jr. Eminent Distinguished Professor and Chair, UNC Department of Neurosurgery and UNC Lineberger member, has been awarded this year’s H. Fleming Fuller Award.
March 10, 2014
Beth Knight found out what transpires inside cells involved in medulloblastoma - a type of brain cancer - and what role a particular protein plays in tumor development.
February 11, 2014
A comprehensive genetic analysis of invasive bladder cancer tumors has found that the disease shares genetic similarities with two forms of breast cancer, according to researchers at the University of North Carolina Lineberger Cancer Center. Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year.
